FDA Inspection 805975 — Actavis
The FDA completed an inspection of Actavis on October 26, 2012 in Bucuresti. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 26, 2012
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bucuresti (Romania)
Additional Details
Postmarket Adverse Drug Experience (PADE)